SP Adds London Office with Formation of Sonenshine Fulford Group

SP adds London office in partnership with leading UK boutique The Fulford Group

Sonenshine Fulford Group (“SFG”) is a co-advisory relationship between Sonenshine Partners (founded in 2000 by Marshall Sonenshine) and The Fulford Group (founded in 2015 by Wilder Fulford).

Marshall Sonenshine and Wilder Fulford have been colleagues for over 25 years since the two worked together at the premier boutique investment bank Wolfensohn & Co. Post-Wolfensohn, Marshall held senior positions within M&A at Bankers Trust and then Deutsche Bank, while Wilder ran the European Healthcare groups for Salomon Brothers, Bank of America and Deutsche Bank.

SFG is focused primarily on Healthcare and Cross-Border M&A. Within Healthcare, SFG combines The Fulford Group’s expertise in the Pharma, Medical Device and MedTech sectors with Sonenshine Partners’ expertise in Medical Devices, Consumer Health & Wellness, Health Retail, and Specialty Health Services (Optical, Audiology, Dermatology, etc.).

About The Fulford Group

The Fulford Group provides independent M&A and strategic and financial advice and execution of the highest quality to companies, entrepreneurs and investors in Life Sciences, Healthcare, and other industries.

About Sonenshine Partners

Established in 2000, Sonenshine Partners is a private investment bank advising major companies worldwide on mergers, acquisitions, corporate finance and restructuring transactions across multiple industry sectors.  With offices in New York and London, Sonenshine Partners brings unique insights, unconflicted advice and extensive dealmaking experience to its global client base.